Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Clinical trial NCT06062498 · RECRUITING

Trial details

NCT number: NCT06062498
Sponsor: Northwestern University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen-receptor-positive Breast Cancer HER2/Neu-Negative Breast Cancer Advanced Breast Cancerv Metastatic Breast Cancer

Start date: 2023-09-29
Primary completion: 2028-07-01
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.